Entrada Therapeutics, Inc.
TRDA
$6.09
-$0.70-10.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.64% | 16.83% | 19.33% | 27.08% | 24.67% |
| Total Receivables | -62.75% | -94.21% | -27.69% | -38.91% | 76.40% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.69% | 95.71% | 38.51% | -46.64% | 76.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.59% | -2.65% | 19.00% | 21.48% | 25.46% |
|
|
|||||
| Total Current Assets | -24.59% | -2.65% | 19.00% | 21.48% | 25.46% |
| Net Property, Plant & Equipment | -13.95% | -12.08% | -11.47% | -11.05% | -11.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -11.67% | -37.59% | -37.18% | -32.25% | 4.66% |
| Total Assets | -22.88% | -4.77% | 12.18% | 14.34% | 17.81% |
|
|
|||||
| Total Accounts Payable | 13.58% | -13.42% | 29.97% | 71.81% | -32.49% |
| Total Accrued Expenses | 12.11% | -16.79% | 19.21% | 43.59% | 68.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -36.24% | -21.58% | -4.43% | 16.50% | 15.63% |
| Total Finance Division Other Current Liabilities | -98.23% | -98.04% | -88.81% | -67.10% | -40.50% |
| Total Other Current Liabilities | -98.23% | -98.04% | -88.81% | -67.10% | -40.50% |
| Total Current Liabilities | -76.92% | -89.40% | -75.14% | -57.32% | -31.87% |
|
|
|||||
| Total Current Liabilities | -76.92% | -89.40% | -75.14% | -57.32% | -31.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.80% | -13.15% | -14.38% | -14.18% | -14.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.13% | -96.80% | -15.58% | -24.20% | -89.16% |
| Total Liabilities | -54.43% | -71.34% | -56.95% | -44.56% | -47.04% |
|
|
|||||
| Common Stock & APIC | 4.06% | 27.76% | 27.66% | 27.59% | 27.49% |
| Retained Earnings | -62.99% | 14.45% | 33.66% | 29.64% | 47.28% |
| Treasury Stock & Other | 221.58% | 277.64% | -122.05% | 295.97% | 67.26% |
| Total Common Equity | -11.73% | 54.90% | 76.88% | 71.26% | 107.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.73% | 54.90% | 76.88% | 71.26% | 107.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.73% | 54.90% | 76.88% | 71.26% | 107.79% |
|
|
|||||